111 related articles for article (PubMed ID: 9788424)
1. The potentiation of the effect of radiation treatment by intratumoral delivery of cisplatin.
Yapp DT; Lloyd DK; Zhu J; Lehnert SM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):413-20. PubMed ID: 9788424
[TBL] [Abstract][Full Text] [Related]
2. Tumor treatment by sustained intratumoral release of cisplatin: effects of drug alone and combined with radiation.
Yapp DT; Lloyd DK; Zhu J; Lehnert SM
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):497-504. PubMed ID: 9308956
[TBL] [Abstract][Full Text] [Related]
3. Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments.
Berrada M; Yang Z; Lehnert S
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1550-7. PubMed ID: 12459384
[TBL] [Abstract][Full Text] [Related]
4. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin delivery by biodegradable polymer implant is superior to systemic delivery by osmotic pump or i.p. injection in tumor-bearing mice.
Yapp DT; Lloyd DK; Zhu J; Lehnert SM
Anticancer Drugs; 1998 Oct; 9(9):791-6. PubMed ID: 9840725
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
Ning S; Yu N; Brown DM; Kanekal S; Knox SJ
Radiother Oncol; 1999 Feb; 50(2):215-23. PubMed ID: 10368046
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device.
Yapp DT; Lloyd DK; Zhu J; Lehnert S
Radiother Oncol; 1999 Oct; 53(1):77-84. PubMed ID: 10624857
[TBL] [Abstract][Full Text] [Related]
8. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
9. Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft.
Joschko MA; Webster LK; Bishop JF; Groves J; Yuen K; Olver IN; Narayan KN; Ball DL
Cancer Chemother Pharmacol; 1997; 40(6):534-9. PubMed ID: 9332470
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
11. Improvement of combined modality therapy with cisplatin and radiation using intratumoral drug administration in murine tumors.
Begg AC; Deurloo MJ; Kop W; Bartelink H
Radiother Oncol; 1994 May; 31(2):129-37. PubMed ID: 8066192
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
Lelieveld P; Scoles MA; Brown JM; Kallman RF
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
[TBL] [Abstract][Full Text] [Related]
14. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin.
Coughlin CT; Richmond RC
Semin Oncol; 1989 Aug; 16(4 Suppl 6):31-43. PubMed ID: 2669136
[TBL] [Abstract][Full Text] [Related]
15. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation.
Bañuelos CA; Banáth JP; Kim JY; Aquino-Parsons C; Olive PL
Clin Cancer Res; 2009 May; 15(10):3344-53. PubMed ID: 19401347
[TBL] [Abstract][Full Text] [Related]
16. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
Teicher BA; Herman TS; Jones SM
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263
[TBL] [Abstract][Full Text] [Related]
17. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.
Cividalli A; Ceciarelli F; Livdi E; Altavista P; Cruciani G; Marchetti P; Danesi DT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1092-8. PubMed ID: 11958906
[TBL] [Abstract][Full Text] [Related]
19. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors.
Choi KN; Rotman M; Aziz H; Sohn CK; Schulsinger A; Torres C; Har-El G; Chandra P; Bradley T; Rosenthal CJ
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):823-9. PubMed ID: 9369129
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
Zaghloul MS; Dorie MJ; Kallman RF
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
